Labeling

FDA Seeks Comments to Improve Gluten Ingredient Disclosure in Foods

The FDA said it is taking action as a first step to improve transparency in disclosures of ingredients that impact certain health conditions, such as gluten for those with celiac disease, and other established food allergens.

Federal Appeals Court Sides with Natural Grocers in GMO Labeling Case

FSIS Announces Webinars on Voluntary ‘Product of USA’ Labeling Claim

FDA Updates General Food Labeling Requirements Compliance Program

More from Quality Assurance & Food Safety

Samples Collected by FDA Test Positive for C. Botulinum in ByHeart Infant Formula Investigation

FDA Releases Total Diet Study Interface

Wisconsin Cheese Makers Association Offers Student Scholarships